Scientific deep-dive

Does NAD+ Slow Aging? What Human Trials of NMN and NR Actually Show

NAD+ boosters like NMN and nicotinamide riboside raise NAD+ levels, but do they slow aging? Across human trials, effects on muscle, cognition, blood pressure and metabolism were mostly null, with a few small exceptions, and a 2026 review found no outcome trials of IV NAD+ drips.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
9 min read·12 citations

NAD+ boosters, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are sold as anti-aging supplements, and IV NAD+ drips are marketed for longevity. Do they slow aging in people? A 2026 systematic review of 33 human intervention studies found that oral NR and NMN reliably raise NAD+ levels in the blood and are generally well tolerated. But their effects on the things that matter for aging, such as muscle, metabolism, blood vessels and function, “were heterogeneous and often null or endpoint-specific.” The review found no outcome trials of IV NAD+ for anti-aging.[1] Here is what the human trials actually show.

About this article

This article is about NAD+ and aging outcomes in human trials. For weight loss, see NAD+ and weight loss; for energy and fatigue, does NAD+ boost energy?; and for choosing a form, NAD+ vs NMN vs NR. NAD+ products are not FDA-approved to slow aging or treat any condition. This is not medical advice.

The short answer

  • They raise NAD+. NR and NMN increase blood NAD+ in middle-aged and older adults, and NR reaches aging muscle.[2][3][4]
  • Aging outcomes are mostly null. NMN didn't improve muscle mass, grip strength or gait speed in a meta-analysis of older adults.[9] NR didn't improve cognition in mild cognitive impairment,[6] and adding it to exercise didn't lower blood pressure more than exercise alone.[7]
  • A few small positive signals. A slight drop in diastolic blood pressure with NMN (about 2 mmHg),[11] and better arterial stiffness in a rare premature-aging syndrome.[8]
  • Short-term safety looks fine. NMN didn't increase adverse events in trials lasting up to 24 weeks.[10] Long-term effects are unknown.

The idea behind NAD+ boosters

NAD+ is a coenzyme used in energy metabolism and DNA repair. In animal studies its levels decline with age, and raising them improved many measures of aging. The 2026 review found that in rodents, NAD+ augmentation “was frequently associated with improvements in metabolic, mitochondrial, inflammatory, and functional outcomes,” though results varied.[1] The question is whether that carries over to people.

Do the supplements raise NAD+ in people? Yes

This part is well established. In a randomized crossover trial in healthy middle-aged and older adults, six weeks of NR was “well tolerated and effectively stimulates NAD+ metabolism.”[2] In 12 older men, NR for 21 days “elevated the muscle NAD+ metabolome” and lowered some inflammatory cytokines, but did not change mitochondrial energy production in muscle.[3] In healthy older men, NMN at 250 mg a day raised blood NAD+.[4] A 2026 head-to-head study found NR and NMN raised blood NAD+ comparably over 14 days, possibly working partly through gut bacteria.[12]

Do they slow aging? What the outcome trials found

Selected human trials of NAD+ precursors on aging-related outcomes
StudyWhoWhat was givenResult
Prokopidis meta-analysis, 2025Older adults (mean age 61–83)NMN or NRNMN: no effect on muscle mass, grip, gait speed or chair stands
Martens, Alzheimers Dement 202642 older adults with amnestic MCINRBlood NAD+ doubled; no improvement in cognition, brain blood flow or BP
Lin, Geroscience 202554 sedentary adults 55+ with high BPNR + exercise vs placebo + exerciseNo greater BP reduction
Igarashi, NPJ Aging 2022Healthy older menNMN 250 mg/day, 6–12 wkNominal gait-speed and grip improvements; no change in body composition
Yoshino, Science 2021Postmenopausal women with prediabetesNMN, 10 wkBetter muscle insulin sensitivity
Shoji, Aging Cell 2025Werner syndrome (premature aging)NR 1,000 mg/day, crossover, 26 wk per armImproved arterial stiffness; smaller skin ulcers
Zhang meta-analysis, 2026349 adults with elevated BP, 10 RCTsNMNDiastolic BP −2.15 mmHg; systolic not significant overall

Muscle and physical function

A 2025 meta-analysis in older adults found NMN had “no significant effects” on skeletal muscle mass, handgrip strength, gait speed or the five-times sit-to-stand test, and did not improve knee strength or overall physical performance. NR lengthened walking distance in people with peripheral artery disease, but people with mild cognitive impairment did slightly worse on two function tests.[9] An earlier trial in older men reported only “nominally significant” improvements in gait speed and grip that “should be validated in larger studies.”[4]

Brain and cognition

In a 2026 pilot trial in 42 older adults with amnestic mild cognitive impairment, NR doubled blood NAD+ but produced “no improvements in cognitive function (primary outcome), total CBF, or blood pressure.” An exploratory analysis hinted at more blood flow in the hippocampus.[6]

Blood pressure and blood vessels

The 2018 NR trial suggested future studies should look at blood pressure and arterial stiffness.[2] Results since then are modest. A 2026 meta-analysis of 10 NMN trials found diastolic pressure fell by 2.15 mmHg, with no significant overall change in systolic pressure, though systolic pressure fell by 3.94 mmHg in people aged 60 and over.[11] In a 2025 trial in adults 55 and over with high blood pressure, NR plus exercise did not lower daytime systolic pressure more than exercise plus placebo.[7]

Metabolism

The best-known positive result is that 10 weeks of NMN increased muscle insulin sensitivity in postmenopausal women with prediabetes and overweight or obesity.[5] But a 2026 meta-analysis of 15 NMN trials found “no significant effects” on body weight, BMI, fasting glucose, HbA1c, lipids or systolic blood pressure.[10]

A rare premature-aging disease

The clearest benefit came in Werner syndrome, a rare inherited disease that causes accelerated aging. In a crossover trial with 26 weeks on each treatment (52 weeks in total), NR at 1,000 mg a day improved arterial stiffness and reduced skin ulcer area, with no serious adverse events.[8] This is a disease with known NAD+ depletion, so it doesn't tell us whether NR slows normal aging.

What about IV NAD+ drips?

The 2026 systematic review found “no eligible outcomes trials evaluated intravenous or intramuscular NAD⁺ itself for anti-aging or wellness indications.”[1] Whatever the clinic marketing says, there is no controlled human evidence that IV NAD+ slows aging. For cost and what drips actually deliver, see are NAD+ IV drips worth it?

Is it safe?

In the short term, it appears so. A 2026 meta-analysis of NMN trials at 250–2,000 mg a day for 14 days to 24 weeks found NMN “did not increase overall, serious, withdrawal-related, or system-specific adverse events, nor did it significantly elevate ALT or AST” liver enzymes.[10] There are no long-term safety data in healthy people.

How NAD+ compares with GLP-1 drugs for longevity

The contrast is stark. Semaglutide has large randomized trials showing about 20% fewer deaths from any cause in people at high risk. See semaglutide and longevity. NAD+ precursors have no trial measuring survival, only small studies of biomarkers and function, most of them null. For the wider landscape, see our metabolic longevity drugs and supplements overview.

Bottom line

NR and NMN do what they claim at the biochemical level: they raise NAD+ in the blood and muscle. But across dozens of human studies, that hasn't translated into measurably slower aging. Muscle, cognition, blood pressure and metabolism mostly didn't improve, with small exceptions. They appear safe in the short term. If you take them, take them as an unproven experiment, not as a longevity treatment.

Frequently Asked Questions

There is no good evidence that it does. A 2026 systematic review of 33 human studies found that NR and NMN reliably raise NAD+ levels, but their effects on aging-related outcomes such as muscle, metabolism, blood vessels and function were mixed and often null. No trial has measured whether they extend life.
Not in pooled trials. A 2025 meta-analysis in older adults found NMN had no significant effect on muscle mass, grip strength, gait speed or chair-stand performance. One earlier trial reported small, nominally significant gains in gait speed and grip that needed confirmation.
There is no controlled evidence. A 2026 systematic review found no outcome trials of intravenous or intramuscular NAD+ for anti-aging or wellness.
They appear safe in the short term. A 2026 meta-analysis of NMN trials lasting up to 24 weeks at 250 to 2,000 mg a day found no increase in adverse events or liver enzymes. Long-term safety in healthy people has not been studied.

References

  1. 1.Gallagher C, Emmanuel OO NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence Ageing Res Rev. 2026;116:103057. 2026. PMID: 41655607.
  2. 2.Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults Nat Commun. 2018;9(1):1286. 2018. PMID: 29599478.
  3. 3.Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures Cell Rep. 2019;28(7):1717-1728.e6. 2019. PMID: 31412242.
  4. 4.Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men NPJ Aging. 2022;8(1):5. 2022. PMID: 35927255.
  5. 5.Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women Science. 2021;372(6547):1224-1229. 2021. PMID: 33888596.
  6. 6.Martens CR, Decker KP, DeConne TM, Sanjana F, Horvat F, Rizzi NA, et al. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment Alzheimers Dement. 2026;22(7):e71605. 2026. PMID: 42478598.
  7. 7.Lin Y, Zeidan RS, Lapierre-Nguyen S, Costello HM, Anton SD, Buford TW, et al. Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial Geroscience. 2025;47(6):6895-6908. 2025. PMID: 40770531.
  8. 8.Shoji M, Kato H, Koshizaka M, Kaneko H, Baba Y, Ishikawa T, et al. Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial Aging Cell. 2025;24(8):e70093. 2025. PMID: 40459998.
  9. 9.Prokopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis J Cachexia Sarcopenia Muscle. 2025;16(3):e13799. 2025. PMID: 40275690.
  10. 10.Yang W, Huang J, Tang Z, Chen C, Sun Y Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis Nutrients. 2026;18(14):2251. 2026. PMID: 42514320.
  11. 11.Zhang M, Chen Y, Jiang N, Zeng J, Zhang J, Wu C, et al. Effects of Nicotinamide Mononucleotide Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Nutrients. 2026;18(6):890. 2026. PMID: 41901064.
  12. 12.Christen S, Redeuil K, Goulet L, Giner MP, Breton I, Rota R, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans Nat Metab. 2026;8(1):62-73. 2026. PMID: 41540253.

NAD+ vs NMN vs NR: Which Precursor Actually Works?

A PMID-verified comparison of nicotinamide riboside, NMN, and IV NAD+ infusion - covering human trial evidence, mechanisms, and metabolic claims.

10 min read

NAD+ IV Drips: Cost, Claims & Is It Worth It?

IV NAD+ drips cost $200-$1,000+ per session and have zero published RCTs for energy, anti-aging, or addiction. Oral NR and NMN are better-studied and cheaper. An honest evidence verdict.

14 min read

Does Semaglutide Help You Live Longer? Longevity, Mortality and Aging Evidence

In randomized trials, deaths from any cause were about 20% lower on semaglutide in people with heart or kidney disease. What SELECT, FLOW and SOUL show, the early aging-clock and mouse lifespan data, and where longevity hype goes too far.

8 min read

Humanin: Mitochondrial-Derived Peptide Evidence Review

Humanin is a mitochondrial-derived peptide encoded in the MT-RNR2 locus. Strong preclinical data and human observational associations with aging exist, but no human interventional trial has tested injected humanin for metabolism, weight loss, or longevity.

9 min read

Does NAD+ Boost Energy? What the Evidence Says (and GLP-1 Fatigue)

NAD+ precursors (NMN, NR) raise NAD+ in blood and muscle but human RCTs have not shown improved energy or fatigue. IV drips have no controlled trials.

12 min read

NAD+ IV for Addiction Recovery: Does It Actually Work?

IV NAD+ is marketed for opioid, alcohol, and benzodiazepine withdrawal — but there are zero published RCTs. The only clinical data is an uncontrolled 50-patient pilot with a conflict of interest. An honest review.

12 min read

Where to get GLP-1 safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.9

TMates

Nationwide compounded GLP-1 availability including Puerto Rico

Read full review →

Pricing Compare

Get started →
7.7

Ivim Health

Compounded GLP-1 with weekly provider check-ins and health coaches, under a required monthly membership

Read full review →

Pricing Compare

Get started →
6.2

Wellorithm

Compounded GLP-1 access with oral tablet options across 49 states

Read full review →

Pricing Compare

Get started →